A Phase 1b/2 Study of Pinometostat in Combination With Standard Induction Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia With MLL Rearrangement
Phase of Trial: Phase I/II
Latest Information Update: 20 Nov 2019
Price : $35 *
At a glance
- Drugs Pinometostat (Primary) ; Cytarabine; Daunorubicin
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 08 May 2019 Planned End Date changed from 30 Jun 2019 to 1 Jun 2020.
- 08 May 2019 Planned primary completion date changed from 30 Jun 2019 to 1 Jun 2020.
- 12 Feb 2019 Status changed from not yet recruiting to recruiting.